The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term strategy.

Asahi Kasei acquires Aicuris for €780M ($920M), adding anti-infective assets to its transplant and nephrology specialty pharmaceutical platform.

In today’s digitally transformed world, technology plays a critical role in how pharmaceutical companies do business. From drug discovery to manufacturing and commercialization, technology is powering ...

PharmTech is rebranding to strengthen its commitment to scientists, innovators, and executives in the pharmaceutical industry. The company is introducing a new look, refined content strategy, and ...

MINNEAPOLIS--(BUSINESS WIRE)--The National Institute for Pharmaceutical Technology and Education (NIPTE) and U.S. Pharmacopeia (USP) today announced the initiation of a joint effort to create the ...

Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Technology as a route for improving pharmaceutical outcomes is anything but novel. For years, it has been the competitive edge leveraged by big pharma in the quest to optimize both the scope and ...